Rhythm Pharmaceuticals, Inc. RYTM Free cash flow
Discontinued — last reported Q4 '25
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Rhythm Pharmaceuticals, Inc.’s reported figures.
The official record: Rhythm Pharmaceuticals, Inc.’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rhythm Pharmaceuticals, Inc.'s free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rhythm Pharmaceuticals, Inc.'s free cash flow?
- Rhythm Pharmaceuticals, Inc. (RYTM) reported free cash flow of -$29.16M in Q4 2025.
- How has Rhythm Pharmaceuticals, Inc.'s free cash flow changed year-over-year?
- Rhythm Pharmaceuticals, Inc.'s free cash flow decreased by 2.4% year-over-year, from -$28.47M to -$29.16M.
- What is the long-term trend for Rhythm Pharmaceuticals, Inc.'s free cash flow?
- Over 4 years (2021 to 2025), Rhythm Pharmaceuticals, Inc.'s free cash flow has grown at a -5.5% compound annual growth rate (CAGR), from -$146.44M to -$116.63M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.